John Reed

EVP, Pharmaceuticals, Research & Development

Mike Varney

Former Exectutive VP, Genentech Research & Early Development, Genentech

Mira Chaurushiya

Managing Director

Westlake Village BioPartners

Ben Cravatt

Professor, The Scripps Research Institute

Marianne De

CEO, Vir Biotechnology

Steve Bartz

Vice President Corporate Development, Seattle Genetics

Dan Estes

General Partner, Frazier Healthcare Partners

Stephen Ferruolo, J.D., Ph.D.

Secretary; Dean,

USD School of Law

Rusty Gage

President, Salk Institute

Carol Gallagher

Venture Advisor, New Enterprise Associates, Inc. (NEA)

Kevin Grimes

Professor of Chemical and Systems Biology; Co-director of the SPARK Program at Stanford University School of Medicine

Jeff Hatfield

CEO, Vividion

Grace Han

AVP and Head, Pacific BD&L

Katie Hewitt

Chief Business Officer, Lilly New Ventures at Eli Lilly and Company

Richard Heyman, Ph.D.

Co-founder & Chairman of the Board

ORIC Pharmaceuticals

John Hood

Founder, CEO and Executive Chairman

Mike Jung

Distinguished Professor of Chemistry, UCLA

Chau Quang Khuong

General Partner and Senior Advisor, Catalio Capital Management

Scott Lippman

Distinguished Professor of Medicine, Director of the Moores Cancer Center, Chugai Pharmaceutical Chair, and Associate Vice Chancellor at UC San Diego School of Medicine

Stefan Luzi

Partner, Gilde Healthcare

Carole Nuechterlein

Head, Roche Venture Fund

Scott Platshon

Partner, EcoR1 Capital, LLC

Armin Rump

Director of Global Business Development, Otsuka

Camille Samuels

Partner, Venrock

Jay Stamatis, MBA

Vice President, Head of Business Development and Acquisitions, AbbVie

Matt Tremblay

Chief Operating Officer

Lesley Stolz, Ph.D.

Head, JLABS California

Alex Szidon, PhD

Chief Business Officer, Resilience

Jeffrey Warmke, PhD

Senior Vice President, Search and Evaluation & Alliance Management, Global Business Development, Daiichi Sankyo

Asish Xavier

Vice President, Venture Investments, Johnson & Johnson Innovation – JJDC